New study pinpoints safer blood pressure dosing for moms with preeclampsia

NCT ID NCT06158022

Completed Disease control Sponsor: General Hospital of Ningxia Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 60 women with preeclampsia having a C-section to find the best doses of two drugs (phenylephrine and norepinephrine) to prevent dangerously low blood pressure after spinal anesthesia. The goal was to identify doses that work in 90% of patients. The findings could help doctors manage blood pressure more precisely during delivery, reducing risks for both mother and baby.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Phenylephrine and norepinephrine (vasopressors to raise blood pressure)
What this could lead to: If successful, this could establish precise dosing guidelines to prevent dangerous drops in blood pressure during C-section in women with preeclampsia, improving safety for mothers and babies.
What could go wrong: This is a small, completed dose-finding study (60 participants), not a large trial. The results may not apply to all patients or settings, and the drugs themselves can cause side effects like slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVERSE EFFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVERSE EFFECT

Contacts and locations

Locations

General hospital of Ningxia University

Yinchuan, Ningxia, 750004, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.